HIV, leukemia, and new horizons in molecular therapy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of the Formosan Medical Association = Taiwan yi zhi

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jfma.2013.01.009PMID 24016608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of an HIV-1-Resistant Immune System with CD34+ Hematopoietic Stem Cells Transduced with a Triple-Combination Anti-HIV Lentiviral Vector

  2012cited by this paper
• Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?

  2012cited by this paper
• Chemokine receptor 5 knockout strategies

  2011cited by this paper
• Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

  2011cited by this paper
• RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.

  2011cited by this paper
• T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

  2011cited by this paper
• Intracellular defenses against HIV, viral evasion and novel therapeutic approaches.

  2011cited by this paper
• Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.

  2011cited by this paper
• Efficacy of gene therapy for X-linked severe combined immunodeficiency.

  2010cited by this paper
• RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

  2010cited by this paper
• Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

  2009cited by this paper
• Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2-/-γc-/-) mouse model

  2009cited by this paper
• Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

  2009cited by this paper
• Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution

  2008cited by this paper
• A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma.

  2008cited by this paper
• Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

  2008cited by this paper
• Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias

  2006cited by this paper
• Construction of a minimal HIV-1 variant that selectively replicates in leukemic derived T-cell lines: towards a new virotherapy approach.

  2005cited by this paper
• A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

  2000cited by this paper
• Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

  1999cited by this paper
• Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains

  1999cited by this paper
• Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

  1992cited by this paper
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

  1981cited by this paper

• Ethics Considerations Regarding the Cancer Moonshot Initiative

  2017cites this paper
• Research Ethics Considerations Regarding the Cancer Moonshot Initiative.

  2016cites this paper
• HIV Infection and Adipose Tissue Resident Stem Cells: Their Involvement in Pathology and Treatment

  2015cites this paper